Prognostic model for overall survival that includes the combination of platelet count and neutrophil–lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma

BACKGROUND: The association between the combination of platelet count and neutrophil–lymphocyte ratio (COP-NLR) at the time of adverse events during sunitinib treatment and prognosis is unclear, and prognostic models combining the prognostic factors of sunitinib have not been well studied. Thus, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Miki Takenaka, Ida, Ayuki, Kanda, Yuki, Takano, Kaori, Ohbayashi, Masayuki, Kohyama, Noriko, Morita, Jun, Fuji, Kohzo, Sasaki, Haruaki, Ogawa, Yoshio, Kogo, Mari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700994/
https://www.ncbi.nlm.nih.gov/pubmed/36434552
http://dx.doi.org/10.1186/s12885-022-10316-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700994/
https://www.ncbi.nlm.nih.gov/pubmed/36434552
http://dx.doi.org/10.1186/s12885-022-10316-w

Ejemplares similares